Telomere Length

Telomeres are the repetitive DNA caps at the ends of chromosomes that shorten with every cell division and reflect cumulative cellular replicative history. Average leukocyte telomere length is a population-level aging proxy that correlates with chronological age, chronic-disease incidence, and mortality in large cohorts. Individual measurements are noisy enough that single readings should be interpreted as a trend across years, not as a precise diagnostic number.

Optimal range

Range varies by individual.

Test frequency

Once at baseline, then every two to three years if you choose to track it. Most longevity-tracking budgets are better spent on epigenetic age and PhenoAge composites, which track mortality risk more tightly and respond faster to interventions.

When to measure

Take an informed baseline once, ideally after a stable period (no recent acute illness, no recent intense training block, normal stress). Re-measure every two to three years to track trajectory. More frequent measurement is wasted because within-person noise dominates short intervals. Avoid measuring during acute illness or immediately after major life stress, which transiently shifts the result.

How to measure

Commercial leukocyte telomere length tests via quantitative PCR or flow-FISH are available from Life Length, Repeat Diagnostics, and TeloYears at $100–$400. Saliva-based variants are slightly less accurate than blood. Methodologies vary substantially between labs, so stick with one provider for trend comparisons. Report formats give an average length in kilobases and a percentile against age-matched reference cohort.

Why this biomarker matters

Across cohorts of healthy adults, shorter age-adjusted telomere length associates with higher risk of cardiovascular disease, type 2 diabetes, certain cancers, and all-cause mortality. The relationship is consistent in observational data but the effect size per individual measurement is small, partly because population telomere distributions overlap heavily across age decades. Telomere length is also influenced by chronic inflammation, oxidative stress, psychological stress, and sleep, accelerated shortening is one of the few biomarkers that responds to stress-reduction interventions in small randomized trials. Where telomere length adds value over PhenoAge or epigenetic clocks is uncertain. The epigenetic clocks tend to track mortality risk more tightly. Telomere length is more useful as a long-term trend metric, measured every few years against a personal baseline, than as a single-time risk stratifier. Telomerase activators and stress-reduction interventions show small effects in published studies; whether any of these translates into hard outcome benefit is still early-stage and unresolved.

The prime report

Weekly performance intelligence.

New studies, protocols, and optimization frameworks delivered every Monday. No fluff, no motivation quotes — only what moves the needle.